event tracking

Cancer

163 results.

February 4, 2026 Cancer research in 2026: What’s new? What’s next?

Cancer research saves lives.

For the first time, the five-year survival rate for all cancers combined has hit 70% among people diagnosed from 2015–2021 in…

February 2, 2026 Hello from the CSO: A message from Dr. Jonathan D. Licht

Today, I enthusiastically begin my work as president and chief scientific officer of Van Andel Institute.

I’ve long admired VAI’s commitment to discovery, collaboration…

December 19, 2025 Reflecting on research: 2025 highlights

In 2025, VAI continued to build scientific momentum and drive discoveries that deepen our understanding of human health. With the addition of new faculty and…

December 9, 2025 Study reveals how dietary restriction helps fuel cancer-fighting immune cells

GRAND RAPIDS, Mich. (Dec. 9, 2025) — Reducing calorie intake helps cancer-fighting immune cells do their jobs more effectively, reports a study by Van Andel Institute

November 20, 2025 Facing cancer with family and focus

"One of the most emotional moments after being diagnosed with breast cancer was telling my parents and children," Brandi Huyser recalls. As the initial shock…

November 4, 2025 Fighting to outsmart cancer: A Q&A with graduate student Yanqing Liu

Cancers are notorious for finding ways to resist treatment.

Van Andel Institute’s Yanqing Liu, a Ph.D. student in the lab of Scott Rothbart,…

October 29, 2025 Eminent physician-scientist Dr. Jonathan D. Licht to serve as next president and chief scientific officer of Van Andel Institute

Grand Rapids, Mich. (Oct. 29, 2025) — Van Andel Institute, a leading research organization based in Grand Rapids, Michigan, has appointed internationally recognized physician-scientist…

October 23, 2025 Harnessing the immune system to combat cancer: A Q&A with Postdoctoral Fellow Dr. Michael Dahabieh

Immunotherapies have been a game-changer for cancer.

These powerful treatments work by bolstering the immune system’s ability to detect and kill cancer cells, but they…